Clinical trial

A Study in Chinese Mild to Moderate Hypertensive Patients Comparing the Efficacy…

NCT00250562 · Novartis, Industry · Completed

Key facts

NCT number NCT00250562
Title A Study in Chinese Mild to Moderate Hypertensive Patients Comparing the Efficacy of Co-Diovan With Diovan.
Official title A Multicenter, Double-blind, Randomized, Active Controlled, Parallel Group Trial Comparing the Combinations of Valsartan 80 mg Plus Hydrochlorothiazide 12.5 mg to Valsartan 80 mg in Patients With Mild to Moderate Essential Hypertension Not Adequately Controlled With Valsartan 80mg
Lead sponsor Novartis, Industry
Status Completed
Phase Phase 3
Study type Interventional
Conditions Hypertension
Intervention type Drug
Interventions valsartan plus hydrochlorothiazide
Enrollment 1,171
Start date Oct 1, 2005
Primary completion Jun 1, 2006
Completion Jun 1, 2006
First posted Nov 8, 2005
Last update posted Aug 1, 2017
Countries United States

At a glance

  • 1–9 Study sites
  • No Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies